Teleflex Brand Guidelines: 1943 Aviation Controls, Arrow, Rüsch & a 2025 Sale

A 1943 start, and decades as a conglomerate.

Teleflex is a medical device company with its headquarters in Wayne, Pennsylvania, listed on the New York Stock Exchange. English Wikipedia dates its founding to 1943. The company tells its own beginning in a single line: it says it “started in 1943 as a manufacturer of innovative mechanical controls for the aviation industry,” and adds that what it makes has changed since then, while the way it works has not.

For decades the business was a conglomerate. English Wikipedia describes a company that grew through acquisitions in several markets and lists them by year: Franklin Medical and Warne Surgical Products in 1985, Willy Rüsch AG in 1989, the instrument maker Pilling in 1991, Fehling, Simal, Unimed, Europe Medical and the OEM division of General Medical in 1994, Endoscopy Specialists in 1995 and Asid Bonz in 1996. Not all of them were medical. Wikipedia names Comcorp Technologies, bought in 1997, as a supplier of pedals and other parts for passenger cars and light trucks, and Nextex as a fiber-optic communications business. It traces the move into the design and manufacture of medical devices to 1981, when Teleflex built its Applied Polymer plant in New Hampshire.

The car-parts side left a mark on American patent law. Teleflex sued KSR International, claiming that one of KSR’s products infringed its patent on connecting an adjustable vehicle pedal to an electronic throttle control. On 30 April 2007 the US Supreme Court unanimously reversed an appeals court ruling in Teleflex’s favor and held the disputed claim obvious, English Wikipedia says; the case, KSR v. Teleflex, is described there as a decision on obviousness in patent claims.

Selling the boats, buying the catheters.

The turn to medicine came by selling the rest. In March 2009, English Wikipedia says, Teleflex sold its marine and industrial instrumentation business to Veethree, which kept making the former Teleflex products at its own facility in Manatee County, Florida, and hired about 50 of Teleflex’s workers; in March 2011 it sold its marine division, Teleflex Marine, to the investment firm H.I.G. Capital. By 2011, according to Wikipedia, the company had largely realigned itself as a medical device manufacturer after several years of acquisitions and sales.

Acquisitions then filled out the hospital range. In August 2012 Teleflex agreed to buy the assets of LMA International, adding to its anesthesia devices; in December 2013 it completed its purchase of Vidacare, whose EZ-IO intraosseous devices joined its Arrow product line; in 2017 it agreed to buy NeoTract, the maker of the UroLift system; and in 2020 it bought Z-Medica, according to English Wikipedia. MedTech Dive confirmed in December 2025 that UroLift came to Teleflex through the 2017 NeoTract purchase.

The stock market followed the change. S&P Dow Jones Indices added Teleflex to the S&P 500 on 18 January 2019 and removed it on 24 March 2025, English Wikipedia says.

Today the company calls itself “the home of” eight brands, among them Arrow, LMA, QuikClot and Rüsch. It says more than 14,000 employees work across vascular and interventional access, surgery, anesthesia, cardiac care, urology, emergency medicine and respiratory care, and describes its purpose as improving “the health and quality of people’s lives.” English Wikipedia puts its operations in 40 countries. The company presents its growth as a mix of in-house research and development, outside partnerships and acquisitions.

The category.

Hospital device makers sell to clinicians, purchasing teams and hospital engineers rather than to shoppers, and their brands are built for that audience. Their catalogues and websites tend to show the equipment where it is used: infusion pumps on poles beside a bed, dialysis machines lined up in a treatment room, monitors and consoles in intensive care.

Much of the product is small and disposable, so the pictures often come close. Gloved hands hold a catheter, a cannula or an infusion set; blood tubing is coiled for a dialysis session; a dialyzer or a single-use endoscope is photographed on plain white so that every connector and label can be read. Product names usually lean on model numbers and technical terms rather than on lifestyle words.

People appear too, usually in uniform: nurses and doctors at the bedside, technicians at a workbench, trainers at a company teaching centre. Several makers in this group run their own training facilities for clinicians, and they present them as part of what they sell alongside the devices.

The trade meets at congresses and fairs. Medica in Düsseldorf gathers hospital suppliers from around the world each autumn; ASN Kidney Week, the American Society of Nephrology’s annual meeting, draws dialysis makers; and Digestive Disease Week brings together gastroenterologists and endoscopy suppliers. Stands, booth graphics and congress brochures are where many of these brands are seen at their largest, and this guide sets out what can be checked about each company: who founded it, who owns it, and where it says its products are made.

A planned split that became a sale.

The portfolio is changing again. In February 2025 Teleflex said it would split in two, MedTech Dive reported, by spinning its acute care, interventional urology and OEM businesses into a new, separately listed company, and would buy assets from Biotronik. Endovascular Today reported that Teleflex completed its purchase of substantially all of Biotronik’s vascular intervention business on 1 July that year.

The spin-off was replaced by a sale. On 9 December 2025 Teleflex announced that it had agreed to sell the three businesses: acute care and interventional urology to Intersurgical, an anesthesia and respiratory care company, and the OEM business to the private equity firms Montagu and Kohlberg. The OEM unit, MedTech Dive reported, makes custom catheter components and subassemblies at seven sites in the United States, Mexico and Ireland. Chief executive Liam Kelly said the company switched to a sale after interest from buyers exceeded expectations, the same report said. Teleflex said the remaining company would be built around vascular access, interventional and surgical businesses, Endovascular Today reported.

The OEM sale was completed in August 2026: Medical Design & Outsourcing reported on 4 August 2026 that the business, now independent, had taken the name Ingenyx and is based in Plymouth, Minnesota. English Wikipedia names Jason Weidman as Teleflex’s president and chief executive.

For a design guide, Teleflex shows how one company name can carry several different businesses over eight decades, from aviation controls to car parts, marine instruments and hospital devices sold under product brands such as Arrow and Rüsch. Compare BD, another American maker of catheters and vascular access devices, and B. Braun. For this guide we use a deep navy, white and a muted teal with a sans, an unofficial interpretation; no product or logo is reproduced.

Keep Teleflex’s identity on hand — save it to a board in the Made Good inspiration library.